Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor
HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell lymphoproliferative disorders such as MC. There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (...
Saved in:
| Published in | mBio Vol. 12; no. 6; p. e0276421 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Society for Microbiology
21.12.2021
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2150-7511 2150-7511 |
| DOI | 10.1128/mBio.02764-21 |
Cover
Loading…
| Abstract | HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell lymphoproliferative disorders such as MC.
There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (HCV) infection with autoimmunity. Mixed cryoglobulinemia (MC) is the most common HCV-associated extrahepatic manifestation, which is characterized by B-cell lymphoproliferation and autoantibody production. B-cell activating factor (BAFF) is a member of the tumor necrosis factor family and plays an important role in B-cell proliferation. We explored the roles of hepatocyte-derived exosomal microRNAs (exo-miRNAs) and BAFF in the extrahepatic diseases of HCV infection. The exo-miRNA profiles were explored using a next-generation sequencing approach, followed by quantitative reverse transcription-PCR validation. The Toll-like receptor 7 (TLR7) polymorphism were analyzed using quantitative PCR. The biological function of exo-miRNAs and TLR7 polymorphism in BAFF expression was evaluated by using immunoblotting and enzyme-linked immunosorbent assay. Significantly increased levels of BAFF, exosomes, and TLR7 were found in HCV patients, particularly in those with MC (
P <
0.005). HCV-infected hepatocyte-derived miR-122/let-7b/miR-206 upregulated BAFF expression in human macrophages through exosome transmission and TLR7 activation. Analysis of a TLR7 single-nucleotide polymorphism (rs3853839) revealed that G-allele carriers had increased TLR7 transcripts, resulting in more BAFF expression induced by hepatocyte-derived exo-miR-122, compared to those in C-allele carriers (
P <
0.005). We identified HCV-infected hepatocyte-derived GU-enriched miRNAs (e.g., miR-122/let-7b/miR-206) as a TLR7 ligand that could induce BAFF production in macrophages through exosome transmission. The polymorphism in TLR7 is associated with the BAFF levels induced by exo-miR-122. It may be a potential predisposing factor of MC syndrome development.
IMPORTANCE
HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell lymphoproliferative disorders such as MC. Approximately half of the patients infected with HCV develop MC, but the real reason and regulatory mechanism is still uncertain. Here, we demonstrate a novel relationship between HCV-infected hepatocyte-derived exo-miRNAs, host genetic background in TLR7, and BAFF expression. We validate that HCV-induced GU-enriched miRNAs (e.g., miR-122, let-7b, and miR-206) upregulated BAFF expression through exosome transmission and TLR7 activation. This mechanism of miRNAs action is implicated in HCV-infected hepatocyte–immune system communication and is important in extrahepatic manifestation development, thus representing a possible target for HCV infection and extrahepatic diseases treatment. In addition, we show that a functional polymorphism in TLR7 is a potential predisposing factor of MC development. Our results elucidate the molecular machinery in order to better understand the association of HCV infection with autoimmunity. |
|---|---|
| AbstractList | There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (HCV) infection with autoimmunity. Mixed cryoglobulinemia (MC) is the most common HCV-associated extrahepatic manifestation, which is characterized by B-cell lymphoproliferation and autoantibody production. B-cell activating factor (BAFF) is a member of the tumor necrosis factor family and plays an important role in B-cell proliferation. We explored the roles of hepatocyte-derived exosomal microRNAs (exo-miRNAs) and BAFF in the extrahepatic diseases of HCV infection. The exo-miRNA profiles were explored using a next-generation sequencing approach, followed by quantitative reverse transcription-PCR validation. The Toll-like receptor 7 (TLR7) polymorphism were analyzed using quantitative PCR. The biological function of exo-miRNAs and TLR7 polymorphism in BAFF expression was evaluated by using immunoblotting and enzyme-linked immunosorbent assay. Significantly increased levels of BAFF, exosomes, and TLR7 were found in HCV patients, particularly in those with MC (
0.005). HCV-infected hepatocyte-derived miR-122/let-7b/miR-206 upregulated BAFF expression in human macrophages through exosome transmission and TLR7 activation. Analysis of a TLR7 single-nucleotide polymorphism (rs3853839) revealed that G-allele carriers had increased TLR7 transcripts, resulting in more BAFF expression induced by hepatocyte-derived exo-miR-122, compared to those in C-allele carriers (
0.005). We identified HCV-infected hepatocyte-derived GU-enriched miRNAs (e.g., miR-122/let-7b/miR-206) as a TLR7 ligand that could induce BAFF production in macrophages through exosome transmission. The polymorphism in TLR7 is associated with the BAFF levels induced by exo-miR-122. It may be a potential predisposing factor of MC syndrome development.
HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell lymphoproliferative disorders such as MC. Approximately half of the patients infected with HCV develop MC, but the real reason and regulatory mechanism is still uncertain. Here, we demonstrate a novel relationship between HCV-infected hepatocyte-derived exo-miRNAs, host genetic background in TLR7, and BAFF expression. We validate that HCV-induced GU-enriched miRNAs (e.g., miR-122, let-7b, and miR-206) upregulated BAFF expression through exosome transmission and TLR7 activation. This mechanism of miRNAs action is implicated in HCV-infected hepatocyte-immune system communication and is important in extrahepatic manifestation development, thus representing a possible target for HCV infection and extrahepatic diseases treatment. In addition, we show that a functional polymorphism in TLR7 is a potential predisposing factor of MC development. Our results elucidate the molecular machinery in order to better understand the association of HCV infection with autoimmunity. There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (HCV) infection with autoimmunity. Mixed cryoglobulinemia (MC) is the most common HCV-associated extrahepatic manifestation, which is characterized by B-cell lymphoproliferation and autoantibody production. B-cell activating factor (BAFF) is a member of the tumor necrosis factor family and plays an important role in B-cell proliferation. We explored the roles of hepatocyte-derived exosomal microRNAs (exo-miRNAs) and BAFF in the extrahepatic diseases of HCV infection. The exo-miRNA profiles were explored using a next-generation sequencing approach, followed by quantitative reverse transcription-PCR validation. The Toll-like receptor 7 (TLR7) polymorphism were analyzed using quantitative PCR. The biological function of exo-miRNAs and TLR7 polymorphism in BAFF expression was evaluated by using immunoblotting and enzyme-linked immunosorbent assay. Significantly increased levels of BAFF, exosomes, and TLR7 were found in HCV patients, particularly in those with MC (P < 0.005). HCV-infected hepatocyte-derived miR-122/let-7b/miR-206 upregulated BAFF expression in human macrophages through exosome transmission and TLR7 activation. Analysis of a TLR7 single-nucleotide polymorphism (rs3853839) revealed that G-allele carriers had increased TLR7 transcripts, resulting in more BAFF expression induced by hepatocyte-derived exo-miR-122, compared to those in C-allele carriers (P < 0.005). We identified HCV-infected hepatocyte-derived GU-enriched miRNAs (e.g., miR-122/let-7b/miR-206) as a TLR7 ligand that could induce BAFF production in macrophages through exosome transmission. The polymorphism in TLR7 is associated with the BAFF levels induced by exo-miR-122. It may be a potential predisposing factor of MC syndrome development. IMPORTANCE HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell lymphoproliferative disorders such as MC. Approximately half of the patients infected with HCV develop MC, but the real reason and regulatory mechanism is still uncertain. Here, we demonstrate a novel relationship between HCV-infected hepatocyte-derived exo-miRNAs, host genetic background in TLR7, and BAFF expression. We validate that HCV-induced GU-enriched miRNAs (e.g., miR-122, let-7b, and miR-206) upregulated BAFF expression through exosome transmission and TLR7 activation. This mechanism of miRNAs action is implicated in HCV-infected hepatocyte–immune system communication and is important in extrahepatic manifestation development, thus representing a possible target for HCV infection and extrahepatic diseases treatment. In addition, we show that a functional polymorphism in TLR7 is a potential predisposing factor of MC development. Our results elucidate the molecular machinery in order to better understand the association of HCV infection with autoimmunity. HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell lymphoproliferative disorders such as MC. There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (HCV) infection with autoimmunity. Mixed cryoglobulinemia (MC) is the most common HCV-associated extrahepatic manifestation, which is characterized by B-cell lymphoproliferation and autoantibody production. B-cell activating factor (BAFF) is a member of the tumor necrosis factor family and plays an important role in B-cell proliferation. We explored the roles of hepatocyte-derived exosomal microRNAs (exo-miRNAs) and BAFF in the extrahepatic diseases of HCV infection. The exo-miRNA profiles were explored using a next-generation sequencing approach, followed by quantitative reverse transcription-PCR validation. The Toll-like receptor 7 (TLR7) polymorphism were analyzed using quantitative PCR. The biological function of exo-miRNAs and TLR7 polymorphism in BAFF expression was evaluated by using immunoblotting and enzyme-linked immunosorbent assay. Significantly increased levels of BAFF, exosomes, and TLR7 were found in HCV patients, particularly in those with MC ( P < 0.005). HCV-infected hepatocyte-derived miR-122/let-7b/miR-206 upregulated BAFF expression in human macrophages through exosome transmission and TLR7 activation. Analysis of a TLR7 single-nucleotide polymorphism (rs3853839) revealed that G-allele carriers had increased TLR7 transcripts, resulting in more BAFF expression induced by hepatocyte-derived exo-miR-122, compared to those in C-allele carriers ( P < 0.005). We identified HCV-infected hepatocyte-derived GU-enriched miRNAs (e.g., miR-122/let-7b/miR-206) as a TLR7 ligand that could induce BAFF production in macrophages through exosome transmission. The polymorphism in TLR7 is associated with the BAFF levels induced by exo-miR-122. It may be a potential predisposing factor of MC syndrome development. IMPORTANCE HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell lymphoproliferative disorders such as MC. Approximately half of the patients infected with HCV develop MC, but the real reason and regulatory mechanism is still uncertain. Here, we demonstrate a novel relationship between HCV-infected hepatocyte-derived exo-miRNAs, host genetic background in TLR7, and BAFF expression. We validate that HCV-induced GU-enriched miRNAs (e.g., miR-122, let-7b, and miR-206) upregulated BAFF expression through exosome transmission and TLR7 activation. This mechanism of miRNAs action is implicated in HCV-infected hepatocyte–immune system communication and is important in extrahepatic manifestation development, thus representing a possible target for HCV infection and extrahepatic diseases treatment. In addition, we show that a functional polymorphism in TLR7 is a potential predisposing factor of MC development. Our results elucidate the molecular machinery in order to better understand the association of HCV infection with autoimmunity. There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (HCV) infection with autoimmunity. Mixed cryoglobulinemia (MC) is the most common HCV-associated extrahepatic manifestation, which is characterized by B-cell lymphoproliferation and autoantibody production. B-cell activating factor (BAFF) is a member of the tumor necrosis factor family and plays an important role in B-cell proliferation. We explored the roles of hepatocyte-derived exosomal microRNAs (exo-miRNAs) and BAFF in the extrahepatic diseases of HCV infection. The exo-miRNA profiles were explored using a next-generation sequencing approach, followed by quantitative reverse transcription-PCR validation. The Toll-like receptor 7 (TLR7) polymorphism were analyzed using quantitative PCR. The biological function of exo-miRNAs and TLR7 polymorphism in BAFF expression was evaluated by using immunoblotting and enzyme-linked immunosorbent assay. Significantly increased levels of BAFF, exosomes, and TLR7 were found in HCV patients, particularly in those with MC ( P < 0.005). HCV-infected hepatocyte-derived miR-122/let-7b/miR-206 upregulated BAFF expression in human macrophages through exosome transmission and TLR7 activation. Analysis of a TLR7 single-nucleotide polymorphism (rs3853839) revealed that G-allele carriers had increased TLR7 transcripts, resulting in more BAFF expression induced by hepatocyte-derived exo-miR-122, compared to those in C-allele carriers ( P < 0.005). We identified HCV-infected hepatocyte-derived GU-enriched miRNAs (e.g., miR-122/let-7b/miR-206) as a TLR7 ligand that could induce BAFF production in macrophages through exosome transmission. The polymorphism in TLR7 is associated with the BAFF levels induced by exo-miR-122. It may be a potential predisposing factor of MC syndrome development. ABSTRACT There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (HCV) infection with autoimmunity. Mixed cryoglobulinemia (MC) is the most common HCV-associated extrahepatic manifestation, which is characterized by B-cell lymphoproliferation and autoantibody production. B-cell activating factor (BAFF) is a member of the tumor necrosis factor family and plays an important role in B-cell proliferation. We explored the roles of hepatocyte-derived exosomal microRNAs (exo-miRNAs) and BAFF in the extrahepatic diseases of HCV infection. The exo-miRNA profiles were explored using a next-generation sequencing approach, followed by quantitative reverse transcription-PCR validation. The Toll-like receptor 7 (TLR7) polymorphism were analyzed using quantitative PCR. The biological function of exo-miRNAs and TLR7 polymorphism in BAFF expression was evaluated by using immunoblotting and enzyme-linked immunosorbent assay. Significantly increased levels of BAFF, exosomes, and TLR7 were found in HCV patients, particularly in those with MC (P < 0.005). HCV-infected hepatocyte-derived miR-122/let-7b/miR-206 upregulated BAFF expression in human macrophages through exosome transmission and TLR7 activation. Analysis of a TLR7 single-nucleotide polymorphism (rs3853839) revealed that G-allele carriers had increased TLR7 transcripts, resulting in more BAFF expression induced by hepatocyte-derived exo-miR-122, compared to those in C-allele carriers (P < 0.005). We identified HCV-infected hepatocyte-derived GU-enriched miRNAs (e.g., miR-122/let-7b/miR-206) as a TLR7 ligand that could induce BAFF production in macrophages through exosome transmission. The polymorphism in TLR7 is associated with the BAFF levels induced by exo-miR-122. It may be a potential predisposing factor of MC syndrome development. IMPORTANCE HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell lymphoproliferative disorders such as MC. Approximately half of the patients infected with HCV develop MC, but the real reason and regulatory mechanism is still uncertain. Here, we demonstrate a novel relationship between HCV-infected hepatocyte-derived exo-miRNAs, host genetic background in TLR7, and BAFF expression. We validate that HCV-induced GU-enriched miRNAs (e.g., miR-122, let-7b, and miR-206) upregulated BAFF expression through exosome transmission and TLR7 activation. This mechanism of miRNAs action is implicated in HCV-infected hepatocyte–immune system communication and is important in extrahepatic manifestation development, thus representing a possible target for HCV infection and extrahepatic diseases treatment. In addition, we show that a functional polymorphism in TLR7 is a potential predisposing factor of MC development. Our results elucidate the molecular machinery in order to better understand the association of HCV infection with autoimmunity. There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (HCV) infection with autoimmunity. Mixed cryoglobulinemia (MC) is the most common HCV-associated extrahepatic manifestation, which is characterized by B-cell lymphoproliferation and autoantibody production. B-cell activating factor (BAFF) is a member of the tumor necrosis factor family and plays an important role in B-cell proliferation. We explored the roles of hepatocyte-derived exosomal microRNAs (exo-miRNAs) and BAFF in the extrahepatic diseases of HCV infection. The exo-miRNA profiles were explored using a next-generation sequencing approach, followed by quantitative reverse transcription-PCR validation. The Toll-like receptor 7 (TLR7) polymorphism were analyzed using quantitative PCR. The biological function of exo-miRNAs and TLR7 polymorphism in BAFF expression was evaluated by using immunoblotting and enzyme-linked immunosorbent assay. Significantly increased levels of BAFF, exosomes, and TLR7 were found in HCV patients, particularly in those with MC (P < 0.005). HCV-infected hepatocyte-derived miR-122/let-7b/miR-206 upregulated BAFF expression in human macrophages through exosome transmission and TLR7 activation. Analysis of a TLR7 single-nucleotide polymorphism (rs3853839) revealed that G-allele carriers had increased TLR7 transcripts, resulting in more BAFF expression induced by hepatocyte-derived exo-miR-122, compared to those in C-allele carriers (P < 0.005). We identified HCV-infected hepatocyte-derived GU-enriched miRNAs (e.g., miR-122/let-7b/miR-206) as a TLR7 ligand that could induce BAFF production in macrophages through exosome transmission. The polymorphism in TLR7 is associated with the BAFF levels induced by exo-miR-122. It may be a potential predisposing factor of MC syndrome development. IMPORTANCE HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell lymphoproliferative disorders such as MC. Approximately half of the patients infected with HCV develop MC, but the real reason and regulatory mechanism is still uncertain. Here, we demonstrate a novel relationship between HCV-infected hepatocyte-derived exo-miRNAs, host genetic background in TLR7, and BAFF expression. We validate that HCV-induced GU-enriched miRNAs (e.g., miR-122, let-7b, and miR-206) upregulated BAFF expression through exosome transmission and TLR7 activation. This mechanism of miRNAs action is implicated in HCV-infected hepatocyte-immune system communication and is important in extrahepatic manifestation development, thus representing a possible target for HCV infection and extrahepatic diseases treatment. In addition, we show that a functional polymorphism in TLR7 is a potential predisposing factor of MC development. Our results elucidate the molecular machinery in order to better understand the association of HCV infection with autoimmunity.There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (HCV) infection with autoimmunity. Mixed cryoglobulinemia (MC) is the most common HCV-associated extrahepatic manifestation, which is characterized by B-cell lymphoproliferation and autoantibody production. B-cell activating factor (BAFF) is a member of the tumor necrosis factor family and plays an important role in B-cell proliferation. We explored the roles of hepatocyte-derived exosomal microRNAs (exo-miRNAs) and BAFF in the extrahepatic diseases of HCV infection. The exo-miRNA profiles were explored using a next-generation sequencing approach, followed by quantitative reverse transcription-PCR validation. The Toll-like receptor 7 (TLR7) polymorphism were analyzed using quantitative PCR. The biological function of exo-miRNAs and TLR7 polymorphism in BAFF expression was evaluated by using immunoblotting and enzyme-linked immunosorbent assay. Significantly increased levels of BAFF, exosomes, and TLR7 were found in HCV patients, particularly in those with MC (P < 0.005). HCV-infected hepatocyte-derived miR-122/let-7b/miR-206 upregulated BAFF expression in human macrophages through exosome transmission and TLR7 activation. Analysis of a TLR7 single-nucleotide polymorphism (rs3853839) revealed that G-allele carriers had increased TLR7 transcripts, resulting in more BAFF expression induced by hepatocyte-derived exo-miR-122, compared to those in C-allele carriers (P < 0.005). We identified HCV-infected hepatocyte-derived GU-enriched miRNAs (e.g., miR-122/let-7b/miR-206) as a TLR7 ligand that could induce BAFF production in macrophages through exosome transmission. The polymorphism in TLR7 is associated with the BAFF levels induced by exo-miR-122. It may be a potential predisposing factor of MC syndrome development. IMPORTANCE HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell lymphoproliferative disorders such as MC. Approximately half of the patients infected with HCV develop MC, but the real reason and regulatory mechanism is still uncertain. Here, we demonstrate a novel relationship between HCV-infected hepatocyte-derived exo-miRNAs, host genetic background in TLR7, and BAFF expression. We validate that HCV-induced GU-enriched miRNAs (e.g., miR-122, let-7b, and miR-206) upregulated BAFF expression through exosome transmission and TLR7 activation. This mechanism of miRNAs action is implicated in HCV-infected hepatocyte-immune system communication and is important in extrahepatic manifestation development, thus representing a possible target for HCV infection and extrahepatic diseases treatment. In addition, we show that a functional polymorphism in TLR7 is a potential predisposing factor of MC development. Our results elucidate the molecular machinery in order to better understand the association of HCV infection with autoimmunity. |
| Author | Liu, Hung-Jen Tang, Kuo-Tung Yang, Sheng-Shun Chen, Der-Yuan Yang, Ying-Ying Liao, Tsai-Ling Hsieh, Shie-Liang Chen, Yi-Ming |
| Author_xml | – sequence: 1 givenname: Tsai-Ling orcidid: 0000-0001-7059-4228 surname: Liao fullname: Liao, Tsai-Ling organization: Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan, Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan – sequence: 2 givenname: Yi-Ming surname: Chen fullname: Chen, Yi-Ming organization: Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan, Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan, Division of Allergy, Immunology, and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan – sequence: 3 givenname: Shie-Liang surname: Hsieh fullname: Hsieh, Shie-Liang organization: Genomics Research Center, Academia Sinica, Taipei, Taiwan, Faculty of Medicine, National Yang Ming University, Taipei, Taiwan – sequence: 4 givenname: Kuo-Tung surname: Tang fullname: Tang, Kuo-Tung organization: Division of Allergy, Immunology, and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan – sequence: 5 givenname: Der-Yuan surname: Chen fullname: Chen, Der-Yuan organization: Translational Medicine Laboratory, Rheumatology and Immunology Center, China Medical University Hospital, Taichung, Taiwan – sequence: 6 givenname: Ying-Ying surname: Yang fullname: Yang, Ying-Ying organization: Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan – sequence: 7 givenname: Hung-Jen orcidid: 0000-0002-1460-1494 surname: Liu fullname: Liu, Hung-Jen organization: Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan, Institute of Molecular Biology, National Chung Hsing University, Taichung, Taiwan, The iEGG and Animal Biotechnology Center, National Chung Hsing University, Taichung, Taiwan – sequence: 8 givenname: Sheng-Shun surname: Yang fullname: Yang, Sheng-Shun organization: Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, School of Medicine, Chung Shan Medical University, Taichung, Taiwan, Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34724826$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kU1P3DAQhqOKqlDKsdfKx6pSqD9j51IJVlBW2n4I0V6tWcdZvHXire2g8u_rZSmCSvji0fidxzPzvq72xjDaqnpL8DEhVH0cTl04xlQ2vKbkRXVAicC1FITsPYr3q6OU1rgcxohi-FW1z7ikXNHmoMoXdgPZZZfQDP10cUr1fOwmYzt09iekMIBHX5yJ4fLrSUIwdugqeF8v3C-LLq2xmxwikuh78LdDiJtrl4aSX00eskWn9cx6j05Mdjflk3GFzsGUgjfVyx58skf392H14_zsanZRL759ns9OFjUIwXMtjBHLloEVFpjtllQ0bY-lVEooTjEHu5RAOIaesTJO3-OmRKyX3HLMlGWH1XzH7QKs9Sa6AeKtDuD0XSLElYaYnfFWd6qBrm-4IkxxpiRIA61RitqlMtSwwvq0Y22m5WA7Y8ccwT-BPn0Z3bVehRutRENYywvg_T0ght-TTVkPLpmyHxhtmJKmoqWMSCbbIv2wk0IaqF6HKY5lTZpgvXVdb13Xd65rSor43ePGHjr653ER1DtBcTGlaPsHyXNA9p_euFzsC9u5nH-m6i-OucoC |
| CitedBy_id | crossref_primary_10_1038_s41598_023_50963_y crossref_primary_10_1016_j_clim_2024_110194 crossref_primary_10_3390_ijms25042144 crossref_primary_10_1039_D4SD00373J crossref_primary_10_1186_s12964_023_01345_4 crossref_primary_10_1186_s12964_024_01730_7 crossref_primary_10_3389_fcimb_2024_1418168 crossref_primary_10_29001_2073_8552_2022_37_4_87_94 crossref_primary_10_1016_j_fsi_2024_110034 crossref_primary_10_3390_biology12101334 crossref_primary_10_1007_s13577_024_01158_8 crossref_primary_10_1128_spectrum_02903_22 crossref_primary_10_1038_s41598_024_71476_2 crossref_primary_10_3389_fimmu_2024_1410273 crossref_primary_10_1007_s00705_023_05744_3 crossref_primary_10_2188_jea_JE20240034 crossref_primary_10_3389_fmicb_2022_1044832 crossref_primary_10_3389_fmicb_2023_1254805 |
| Cites_doi | 10.1038/nrgastro.2013.222 10.1038/nrgastro.2013.87 10.1172/jci.insight.98204 10.1093/rheumatology/kem132 10.1056/NEJM200107053450107 10.1038/sj.gene.6363923 10.1136/ard.61.6.554 10.1002/art.40495 10.1136/ard.2010.138461 10.1016/S1473-3099(05)70053-0 10.1016/j.jaut.2006.07.005 10.15252/embr.201439363 10.1371/journal.pone.0026235 10.1038/nrgastro.2017.71 10.1016/j.jhep.2019.06.029 10.3390/ijms17122028 10.1126/sciimmunol.aap8855 10.1126/science.1093620 10.1093/infdis/jiw235 10.1016/j.jhep.2014.10.004 10.1016/j.chom.2012.08.010 10.1073/pnas.1814139116 10.1016/s0165-2478(03)00050-6 10.1016/j.gene.2014.07.040 10.1073/pnas.1211491109 10.1126/science.1113329 10.1073/pnas.1209414109 10.1200/JCO.2005.02.7938 10.1073/pnas.1518976113 10.1016/j.dld.2014.10.005 10.1155/2014/435476 10.1002/art.30274 10.1128/CMR.00046-17 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D 10.1182/blood-2008-07-170613 10.1007/s00018-012-0940-6 10.1073/pnas.1001337107 10.1042/BSR20181823 10.1016/j.tibs.2016.08.004 10.1016/j.ymthe.2016.12.022 10.1002/art.1780400928 10.1093/rheumatology/kel177 10.1016/s0092-8674(04)00045-5 10.1016/j.autrev.2014.01.027 10.1128/JVI.01219-18 10.1371/journal.ppat.1004424 10.1371/journal.ppat.1004937 10.1111/j.1440-1746.1998.tb00671.x 10.1093/rheumatology/ket006 10.1038/s41598-018-35774-w 10.1084/jem.189.11.1747 |
| ContentType | Journal Article |
| Copyright | Copyright © 2021 Liao et al. Copyright © 2021 Liao et al. 2021 Liao et al. |
| Copyright_xml | – notice: Copyright © 2021 Liao et al. – notice: Copyright © 2021 Liao et al. 2021 Liao et al. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.1128/mBio.02764-21 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2150-7511 |
| Editor | Griffin, Diane E |
| Editor_xml | – sequence: 1 givenname: Diane E surname: Griffin fullname: Griffin, Diane E |
| ExternalDocumentID | oai_doaj_org_article_d86adf6481384387a7ca9c882eb8c2c3 PMC8561394 mBio02764-21 34724826 10_1128_mBio_02764_21 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Taichung Veterans General Hospital (TCVGH) grantid: TCVGH-VTA108V212; TCVGH-VTA109A32; TCVGH-VTA110V552; TCVGH-1107301D funderid: https://doi.org/10.13039/501100010101 – fundername: Academia Sinica(中央研究院) grantid: VTA 108-V2-1-1; VTA 109-A-3-1; VTA 110-A-5-5-1 – fundername: ; grantid: TCVGH-VTA108V212; TCVGH-VTA109A32; TCVGH-VTA110V552; TCVGH-1107301D – fundername: ; grantid: VTA 108-V2-1-1; VTA 109-A-3-1; VTA 110-A-5-5-1 |
| GroupedDBID | --- 0R~ 53G 5VS AAFWJ AAGFI AAUOK AAYXX ADBBV AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BTFSW CITATION DIK E3Z EBS FRP GROUPED_DOAJ GX1 H13 HYE HZ~ KQ8 M48 O5R O5S O9- OK1 P2P PGMZT RHI RNS RPM RSF CGR CUY CVF ECM EIF NPM - 0R ADACO BXI HZ M~E RHF 7X8 5PM |
| ID | FETCH-LOGICAL-a554t-5cc5b93ae5ea3edb2569f07788584204aeb7a140af33248ff06f333f74e4038e3 |
| IEDL.DBID | DOA |
| ISSN | 2150-7511 |
| IngestDate | Wed Aug 27 01:31:25 EDT 2025 Thu Aug 21 14:09:28 EDT 2025 Fri Jul 11 01:58:31 EDT 2025 Tue Feb 01 18:30:49 EST 2022 Thu Apr 03 06:58:31 EDT 2025 Thu Apr 24 23:06:26 EDT 2025 Tue Jul 01 01:52:49 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | hepatitis C virus B-cell activating factor TLR7 exosomal microRNA-122 mixed cryoglobulinemia |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a554t-5cc5b93ae5ea3edb2569f07788584204aeb7a140af33248ff06f333f74e4038e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-1460-1494 0000-0001-7059-4228 |
| OpenAccessLink | https://doaj.org/article/d86adf6481384387a7ca9c882eb8c2c3 |
| PMID | 34724826 |
| PQID | 2592317379 |
| PQPubID | 23479 |
| PageCount | 18 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d86adf6481384387a7ca9c882eb8c2c3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8561394 proquest_miscellaneous_2592317379 asm2_journals_10_1128_mBio_02764_21 pubmed_primary_34724826 crossref_primary_10_1128_mBio_02764_21 crossref_citationtrail_10_1128_mBio_02764_21 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-12-21 |
| PublicationDateYYYYMMDD | 2021-12-21 |
| PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-21 day: 21 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
| PublicationTitle | mBio |
| PublicationTitleAbbrev | mBio |
| PublicationTitleAlternate | mBio |
| PublicationYear | 2021 |
| Publisher | American Society for Microbiology |
| Publisher_xml | – name: American Society for Microbiology |
| References | e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_28_2 e_1_3_2_41_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_50_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 Salvi, V, Gianello, V, Busatto, S, Bergese, P, Andreoli, L, D’Oro, U, Zingoni, A, Tincani, A, Sozzani, S, Bosisio, D (B28) 2018; 3 Sakai, J, Akkoyunlu, M (B38) 2017; 30 Aletaha, D, Neogi, T, Silman, AJ, Funovits, J, Felson, DT, Bingham, CO, Birnbaum, NS, Burmester, GR, Bykerk, VP, Cohen, MD, Combe, B, Costenbader, KH, Dougados, M, Emery, P, Ferraccioli, G, Hazes, JMW, Hobbs, K, Huizinga, TWJ, Kavanaugh, A, Kay, J, Kvien, TK, Laing, T, Mease, P, Ménard, HA, Moreland, LW, Naden, RL, Pincus, T, Smolen, JS, Stanislawska-Biernat, E, Symmons, D, Tak, PP, Upchurch, KS, Vencovsky, J, Wolfe, F, Hawker, G (B50) 2010; 69 Turchinovich, A, Tonevitsky, AG, Burwinkel, B (B13) 2016; 41 Lauer, GM, Walker, BD (B1) 2001; 345 Mei, SL, Burchell, J, Skinner, N, Millen, R, Matthews, G, Hellard, M, Dore, GJ, Desmond, PV, Sundararajan, V, Thompson, AJ, Visvanathan, K, Sasadeusz, J (B21) 2016; 214 Abu-Rish, EY, Amrani, Y, Browning, MJ (B44) 2013; 52 Wang, CH, Eng, HL, Lin, KH, Chang, CH, Hsieh, CA, Lin, YL, Lin, TM (B20) 2011; 6 Shen, N, Fu, Q, Deng, Y, Qian, X, Zhao, J, Kaufman, KM, Wu, YL, Yu, CY, Tang, Y, Chen, J-Y, Yang, W, Wong, M, Kawasaki, A, Tsuchiya, N, Sumida, T, Kawaguchi, Y, Howe, HS, Mok, MY, Bang, S-Y, Liu, F-L, Chang, D-M, Takasaki, Y, Hashimoto, H, Harley, JB, Guthridge, JM, Grossman, JM, Cantor, RM, Song, YW, Bae, S-C, Chen, S, Hahn, BH, Lau, YL, Tsao, BP (B23) 2010; 107 Carbone, CJ, Zheng, H, Bhattacharya, S, Lewis, JR, Reiter, AM, Henthorn, P, Zhang, ZY, Baker, DP, Ukkiramapandian, R, Bence, KK, Fuchs, SY (B34) 2012; 109 Giannini, C, Gragnani, L, Piluso, A, Caini, P, Petrarca, A, Monti, M, Laffi, G, Zignego, AL (B43) 2008; 112 Schneider, P, Tschopp, J (B37) 2003; 88 Cacoub, P, Poynard, T, Ghillani, P, Charlotte, F, Olivi, M, Piette, JC, Opolon, P (B2) 1999; 42 Comarmond, C, Lorin, V, Marques, C, Maciejewski-Duval, A, Joher, N, Planchais, C, Touzot, M, Biard, L, Hieu, T, Quiniou, V, Desbois, A-C, Rosenzwajg, M, Klatzmann, D, Cacoub, P, Mouquet, H, Saadoun, D (B45) 2019; 71 Lee, J, Tian, Y, Chan, ST, Kim, JY, Cho, C, Ou, J-HJ (B46) 2015; 11 Wang, Y, Liang, H, Jin, F, Yan, X, Xu, G, Hu, H, Liang, G, Zhan, S, Hu, X, Zhao, Q, Liu, Y, Jiang, Z-Y, Zhang, C-Y, Chen, X, Zen, K (B35) 2019; 116 Schneider, P, MacKay, F, Steiner, V, Hofmann, K, Bodmer, JL, Holler, N, Ambrose, C, Lawton, P, Bixler, S, Acha-Orbea, H, Valmori, D, Romero, P, Werner-Favre, C, Zubler, RH, Browning, JL, Tschopp, J (B10) 1999; 189 Dominguez-Molina, B, Machmach, K, Perales, C, Tarancon-Diez, L, Gallego, I, Sheldon, JL, Leal, M, Domingo, E, Ruiz-Mateos, E (B22) 2018; 92 Jopling, CL, Yi, M, Lancaster, AM, Lemon, SM, Sarnow, P (B17) 2005; 309 Liao, TL, Huang, YL, Chen, YM, Lee, HC, Chen, DY, Hsieh, SL (B9) 2018; 8 Damoiseaux, J (B7) 2014; 13 Yu, X, Odenthal, M, Fries, JW (B14) 2016; 17 Schorey, JS, Cheng, Y, Singh, PP, Smith, VL (B19) 2015; 16 Vitali, C, Bombardieri, S, Jonsson, R, Moutsopoulos, HM, Alexander, EL, Carsons, SE, Daniels, TE, Fox, PC, Fox, RI, Kassan, SS, Pillemer, SR, Talal, N, Weisman, MH (B49) 2002; 61 Souyris, M, Cenac, C, Azar, P, Daviaud, D, Canivet, A, Grunenwald, S, Pienkowski, C, Chaumeil, J, Mejía, JE, Guéry, JC (B24) 2018; 3 Gragnani, L, Piluso, A, Giannini, C, Caini, P, Fognani, E, Monti, M, Petrarca, A, Ranieri, J, Razzolini, G, Froio, V, Laffi, G, Zignego, AL (B8) 2011; 63 Szabo, G, Bala, S (B16) 2013; 10 Bartel, DP (B12) 2004; 116 Beltrami, C, Besnier, M, Shantikumar, S, Shearn, A, Rajakaruna, C, Laftah, A, Sessa, F, Spinetti, G, Petretto, E, Angelini, GD, Emanueli, C (B15) 2017; 25 Novak, AJ, Grote, DM, Ziesmer, SC, Kline, MP, Manske, MK, Slager, S, Witzig, TE, Shanafelt, T, Call, TG, Kay, NE, Jelinek, DF, Cerhan, JR, Gross, JA, Harder, B, Dillon, SR, Ansell, SM (B42) 2006; 24 Newman, ZR, Young, JM, Ingolia, NT, Barton, GM (B47) 2016; 113 Fabbri, M, Paone, A, Calore, F, Galli, R, Gaudio, E, Santhanam, R, Lovat, F, Fadda, P, Mao, C, Nuovo, GJ, Zanesi, N, Crawford, M, Ozer, GH, Wernicke, D, Alder, H, Caligiuri, MA, Nana-Sinkam, P, Perrotti, D, Croce, CM (B29) 2012; 109 Toubi, E, Gordon, S, Kessel, A, Rosner, I, Rozenbaum, M, Shoenfeld, Y, Zuckerman, E (B11) 2006; 27 Kawasaki, A, Tsuchiya, N, Fukazawa, T, Hashimoto, H, Tokunaga, K (B41) 2002; 3 Sansonno, D, Dammacco, F (B5) 2005; 5 Yang, Q, Zhang, L, Zhong, Y, Lai, L, Li, X (B33) 2019; 39 Bukong, TN, Momen-Heravi, F, Kodys, K, Bala, S, Szabo, G (B25) 2014; 10 Kumar, S, Chawla, Y, Ghosh, S, Chakraborti, A (B36) 2014; 2014 Negro, F (B4) 2014; 11 Heil, F, Hemmi, H, Hochrein, H, Ampenberger, F, Kirschning, C, Akira, S, Lipford, G, Wagner, H, Bauer, S (B30) 2004; 303 Yue, M, Feng, L, Tang, SD, Wang, JJ, Xue, XX, Ding, WL, Zhang, Y, Deng, XZ (B48) 2014; 548 Luo, JC, Hwang, SJ, Li, CP, Lu, RH, Chan, CY, Wu, JC, Chang, FY, Lee, SD (B39) 1998; 13 Szabo, G, Momen-Heravi, F (B26) 2017; 14 Cheng, JC, Yeh, YJ, Tseng, CP, Hsu, SD, Chang, YL, Sakamoto, N, Huang, HD (B32) 2012; 69 Liao, TL, Hsieh, SL, Chen, YM, Chen, HH, Liu, HJ, Lee, HC, Chen, DY (B18) 2018; 70 Cacoub, P, Gragnani, L, Comarmond, C, Zignego, AL (B3) 2014; 46 Saadoun, D, Landau, DA, Calabrese, LH, Cacoub, PP (B6) 2007; 46 Bandiera, S, Pfeffer, S, Baumert, TF, Zeisel, MB (B31) 2015; 62 Dreux, M, Garaigorta, U, Boyd, B, Décembre, E, Chung, J, Whitten-Bauer, C, Wieland, S, Chisari, FV (B27) 2012; 12 Sène, D, Limal, N, Ghillani-Dalbin, P, Saadoun, D, Piette, JC, Cacoub, P (B40) 2007; 46 Hochberg, MC (B51) 1997; 40 |
| References_xml | – ident: e_1_3_2_5_2 doi: 10.1038/nrgastro.2013.222 – ident: e_1_3_2_17_2 doi: 10.1038/nrgastro.2013.87 – ident: e_1_3_2_29_2 doi: 10.1172/jci.insight.98204 – ident: e_1_3_2_7_2 doi: 10.1093/rheumatology/kem132 – ident: e_1_3_2_2_2 doi: 10.1056/NEJM200107053450107 – ident: e_1_3_2_42_2 doi: 10.1038/sj.gene.6363923 – ident: e_1_3_2_50_2 doi: 10.1136/ard.61.6.554 – ident: e_1_3_2_19_2 doi: 10.1002/art.40495 – ident: e_1_3_2_51_2 doi: 10.1136/ard.2010.138461 – ident: e_1_3_2_6_2 doi: 10.1016/S1473-3099(05)70053-0 – ident: e_1_3_2_12_2 doi: 10.1016/j.jaut.2006.07.005 – ident: e_1_3_2_20_2 doi: 10.15252/embr.201439363 – ident: e_1_3_2_21_2 doi: 10.1371/journal.pone.0026235 – ident: e_1_3_2_27_2 doi: 10.1038/nrgastro.2017.71 – ident: e_1_3_2_46_2 doi: 10.1016/j.jhep.2019.06.029 – ident: e_1_3_2_15_2 doi: 10.3390/ijms17122028 – ident: e_1_3_2_25_2 doi: 10.1126/sciimmunol.aap8855 – ident: e_1_3_2_31_2 doi: 10.1126/science.1093620 – ident: e_1_3_2_22_2 doi: 10.1093/infdis/jiw235 – ident: e_1_3_2_32_2 doi: 10.1016/j.jhep.2014.10.004 – ident: e_1_3_2_28_2 doi: 10.1016/j.chom.2012.08.010 – ident: e_1_3_2_36_2 doi: 10.1073/pnas.1814139116 – ident: e_1_3_2_38_2 doi: 10.1016/s0165-2478(03)00050-6 – ident: e_1_3_2_49_2 doi: 10.1016/j.gene.2014.07.040 – ident: e_1_3_2_35_2 doi: 10.1073/pnas.1211491109 – ident: e_1_3_2_18_2 doi: 10.1126/science.1113329 – ident: e_1_3_2_30_2 doi: 10.1073/pnas.1209414109 – ident: e_1_3_2_43_2 doi: 10.1200/JCO.2005.02.7938 – ident: e_1_3_2_48_2 doi: 10.1073/pnas.1518976113 – ident: e_1_3_2_4_2 doi: 10.1016/j.dld.2014.10.005 – ident: e_1_3_2_37_2 doi: 10.1155/2014/435476 – ident: e_1_3_2_9_2 doi: 10.1002/art.30274 – ident: e_1_3_2_39_2 doi: 10.1128/CMR.00046-17 – ident: e_1_3_2_3_2 doi: 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D – ident: e_1_3_2_44_2 doi: 10.1182/blood-2008-07-170613 – ident: e_1_3_2_33_2 doi: 10.1007/s00018-012-0940-6 – ident: e_1_3_2_24_2 doi: 10.1073/pnas.1001337107 – ident: e_1_3_2_34_2 doi: 10.1042/BSR20181823 – ident: e_1_3_2_14_2 doi: 10.1016/j.tibs.2016.08.004 – ident: e_1_3_2_16_2 doi: 10.1016/j.ymthe.2016.12.022 – ident: e_1_3_2_52_2 doi: 10.1002/art.1780400928 – ident: e_1_3_2_41_2 doi: 10.1093/rheumatology/kel177 – ident: e_1_3_2_13_2 doi: 10.1016/s0092-8674(04)00045-5 – ident: e_1_3_2_8_2 doi: 10.1016/j.autrev.2014.01.027 – ident: e_1_3_2_23_2 doi: 10.1128/JVI.01219-18 – ident: e_1_3_2_26_2 doi: 10.1371/journal.ppat.1004424 – ident: e_1_3_2_47_2 doi: 10.1371/journal.ppat.1004937 – ident: e_1_3_2_40_2 doi: 10.1111/j.1440-1746.1998.tb00671.x – ident: e_1_3_2_45_2 doi: 10.1093/rheumatology/ket006 – ident: e_1_3_2_10_2 doi: 10.1038/s41598-018-35774-w – ident: e_1_3_2_11_2 doi: 10.1084/jem.189.11.1747 – volume: 345 start-page: 41 year: 2001 end-page: 52 ident: B1 article-title: Hepatitis C virus infection publication-title: N Engl J Med doi: 10.1056/NEJM200107053450107 – volume: 24 start-page: 983 year: 2006 end-page: 987 ident: B42 article-title: Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders publication-title: J Clin Oncol doi: 10.1200/JCO.2005.02.7938 – volume: 107 start-page: 15838 year: 2010 end-page: 15843 ident: B23 article-title: Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1001337107 – volume: 92 year: 2018 ident: B22 article-title: Toll-like receptor 7 (TLR-7) and TLR-9 agonists improve hepatitis C virus replication and infectivity inhibition by plasmacytoid dendritic cells publication-title: J Virol doi: 10.1128/JVI.01219-18 – volume: 109 start-page: E2110 year: 2012 end-page: E2116 ident: B29 article-title: MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1209414109 – volume: 548 start-page: 244 year: 2014 end-page: 250 ident: B48 article-title: Sex-specific association between X-linked Toll-like receptor 7 with the outcomes of hepatitis C virus infection publication-title: Gene doi: 10.1016/j.gene.2014.07.040 – volume: 309 start-page: 1577 year: 2005 end-page: 1581 ident: B17 article-title: Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA publication-title: Science doi: 10.1126/science.1113329 – volume: 69 start-page: 2621 year: 2012 end-page: 2633 ident: B32 article-title: Let-7b is a novel regulator of hepatitis C virus replication publication-title: Cell Mol Life Sci doi: 10.1007/s00018-012-0940-6 – volume: 39 start-page: BSR20181823 year: 2019 ident: B33 article-title: miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma publication-title: Biosci Rep doi: 10.1042/BSR20181823 – volume: 27 start-page: 134 year: 2006 end-page: 139 ident: B11 article-title: Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity publication-title: J Autoimmun doi: 10.1016/j.jaut.2006.07.005 – volume: 116 start-page: 6162 year: 2019 end-page: 6171 ident: B35 article-title: Injured liver-released miRNA-122 elicits acute pulmonary inflammation via activating alveolar macrophage TLR7 signaling pathway publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1814139116 – volume: 13 start-page: 359 year: 2014 end-page: 362 ident: B7 article-title: The diagnosis and classification of the cryoglobulinemic syndrome publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2014.01.027 – volume: 46 start-page: 1234 year: 2007 end-page: 1242 ident: B6 article-title: Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kem132 – volume: 3 start-page: 10 year: 2018 ident: B28 article-title: Exosome-delivered microRNAs promote IFN-alpha secretion by human plasmacytoid DCs via TLR7 publication-title: JCI Insight doi: 10.1172/jci.insight.98204 – volume: 41 start-page: 883 year: 2016 end-page: 892 ident: B13 article-title: Extracellular miRNA: a collision of two paradigms publication-title: Trends Biochem Sci doi: 10.1016/j.tibs.2016.08.004 – volume: 16 start-page: 24 year: 2015 end-page: 43 ident: B19 article-title: Exosomes and other extracellular vesicles in host-pathogen interactions publication-title: EMBO Rep doi: 10.15252/embr.201439363 – volume: 11 start-page: 77 year: 2014 end-page: 78 ident: B4 article-title: Hepatitis C in 2013: HCV causes systemic disorders that can be cured publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2013.222 – volume: 8 start-page: 17287 year: 2018 ident: B9 article-title: Association of C-type lectin 18 levels with extrahepatic manifestations in chronic HCV infection publication-title: Sci Rep doi: 10.1038/s41598-018-35774-w – volume: 2014 start-page: 1 year: 2014 end-page: 6 ident: B36 article-title: Severity of hepatitis C virus (genotype-3) infection positively correlates with circulating microRNA-122 in patient sera publication-title: Dis Markers doi: 10.1155/2014/435476 – volume: 25 start-page: 679 year: 2017 end-page: 693 ident: B15 article-title: Human pericardial fluid contains exosomes enriched with cardiovascular-expressed MicroRNAs and promotes therapeutic angiogenesis publication-title: Mol Ther doi: 10.1016/j.ymthe.2016.12.022 – volume: 46 start-page: S165 year: 2014 end-page: S173 ident: B3 article-title: Extrahepatic manifestations of chronic hepatitis C virus infection publication-title: Dig Liver Dis doi: 10.1016/j.dld.2014.10.005 – volume: 30 start-page: 991 year: 2017 end-page: 1014 ident: B38 article-title: The role of BAFF system molecules in host response to pathogens publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00046-17 – volume: 69 start-page: 1580 year: 2010 end-page: 1588 ident: B50 article-title: The 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative publication-title: Ann Rheum Dis doi: 10.1136/ard.2010.138461 – volume: 109 start-page: 19226 year: 2012 end-page: 19231 ident: B34 article-title: Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1211491109 – volume: 46 start-page: 65 year: 2007 end-page: 69 ident: B40 article-title: Hepatitis C virus-associated B-cell proliferation–the role of serum B lymphocyte stimulator (BLyS/BAFF) publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kel177 – volume: 52 start-page: 1190 year: 2013 end-page: 1201 ident: B44 article-title: Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/ket006 – volume: 17 start-page: 2028 year: 2016 ident: B14 article-title: Exosomes as miRNA carriers: formation-function-future publication-title: Int J Mol Sci doi: 10.3390/ijms17122028 – volume: 5 start-page: 227 year: 2005 end-page: 236 ident: B5 article-title: Hepatitis C virus, cryoglobulinemia, and vasculitis: immune complex relations publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(05)70053-0 – volume: 10 start-page: 542 year: 2013 end-page: 552 ident: B16 article-title: MicroRNAs in liver disease publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2013.87 – volume: 10 year: 2014 ident: B25 article-title: Exosomes from hepatitis C-infected patients transmit HCV infection and contain replication-competent viral RNA in complex with Ago2-miR122-HSP90 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1004424 – volume: 189 start-page: 1747 year: 1999 end-page: 1756 ident: B10 article-title: BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth publication-title: J Exp Med doi: 10.1084/jem.189.11.1747 – volume: 6 year: 2011 ident: B20 article-title: TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection publication-title: PLoS One doi: 10.1371/journal.pone.0026235 – volume: 42 start-page: 2204 year: 1999 end-page: 2212 ident: B2 article-title: Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group publication-title: Multidepartment Virus C Arthritis Rheum doi: 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D – volume: 11 year: 2015 ident: B46 article-title: TNF-α induced by hepatitis C virus via TLR7 and TLR8 in hepatocytes supports interferon signaling via an autocrine mechanism publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1004937 – volume: 40 start-page: 1725 year: 1997 ident: B51 article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780400928 – volume: 13 start-page: 475 year: 1998 end-page: 479 ident: B39 article-title: Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: negative role of serum viral titre and genotype publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.1998.tb00671.x – volume: 62 start-page: 448 year: 2015 end-page: 457 ident: B31 article-title: miR-122: a key factor and therapeutic target in liver disease publication-title: J Hepatol doi: 10.1016/j.jhep.2014.10.004 – volume: 214 start-page: 739 year: 2016 end-page: 747 ident: B21 article-title: Toll-like receptor expression and signaling in peripheral blood mononuclear cells correlate with clinical outcomes in acute hepatitis C virus infection publication-title: J Infect Dis doi: 10.1093/infdis/jiw235 – volume: 63 start-page: 1446 year: 2011 end-page: 1451 ident: B8 article-title: Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors publication-title: Arthritis Rheum doi: 10.1002/art.30274 – volume: 14 start-page: 455 year: 2017 end-page: 466 ident: B26 article-title: Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2017.71 – volume: 116 start-page: 281 year: 2004 end-page: 297 ident: B12 article-title: MicroRNAs: genomics, biogenesis, mechanism, and function publication-title: Cell doi: 10.1016/s0092-8674(04)00045-5 – volume: 3 start-page: 424 year: 2002 end-page: 429 ident: B41 article-title: Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis publication-title: Genes Immun doi: 10.1038/sj.gene.6363923 – volume: 70 start-page: 1209 year: 2018 end-page: 1219 ident: B18 article-title: Rituximab may cause increased hepatitis C virus viremia in rheumatoid arthritis patients through declining exosomal microRNA-155 publication-title: Arthritis Rheumatol doi: 10.1002/art.40495 – volume: 88 start-page: 57 year: 2003 end-page: 62 ident: B37 article-title: BAFF and the regulation of B cell survival publication-title: Immunol Lett doi: 10.1016/s0165-2478(03)00050-6 – volume: 12 start-page: 558 year: 2012 end-page: 570 ident: B27 article-title: Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity publication-title: Cell Host Microbe doi: 10.1016/j.chom.2012.08.010 – volume: 303 start-page: 1526 year: 2004 end-page: 1529 ident: B30 article-title: Species-specific recognition of single-stranded RNA via Toll-like receptors 7 and 8 publication-title: Science doi: 10.1126/science.1093620 – volume: 61 start-page: 554 year: 2002 end-page: 558 ident: B49 article-title: Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group publication-title: Ann Rheum Dis doi: 10.1136/ard.61.6.554 – volume: 3 year: 2018 ident: B24 article-title: TLR7 escapes X chromosome inactivation in immune cells publication-title: Sci Immunol doi: 10.1126/sciimmunol.aap8855 – volume: 113 start-page: E1362 year: 2016 end-page: E1371 ident: B47 article-title: Differences in codon bias and GC content contribute to the balanced expression of TLR7 and TLR9 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1518976113 – volume: 112 start-page: 4353 year: 2008 end-page: 4354 ident: B43 article-title: Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? publication-title: Blood doi: 10.1182/blood-2008-07-170613 – volume: 71 start-page: 908 year: 2019 end-page: 919 ident: B45 article-title: TLR9 signaling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses publication-title: J Hepatol doi: 10.1016/j.jhep.2019.06.029 |
| SSID | ssj0000331830 |
| Score | 2.4140868 |
| Snippet | HCV remains an important cause of liver disease worldwide. Accumulating evidence has demonstrated that HCV infection is associated with B cell... There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (HCV) infection with autoimmunity. Mixed... ABSTRACT There are large gaps in understanding the molecular machinery accounting for the association of hepatitis C virus (HCV) infection with autoimmunity.... |
| SourceID | doaj pubmedcentral proquest asm2 pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0276421 |
| SubjectTerms | B-cell activating factor B-Cell Activating Factor - genetics B-Cell Activating Factor - metabolism exosomal microRNA-122 Exosomes - genetics Exosomes - metabolism Gene Expression Profiling Hepacivirus - genetics Hepacivirus - physiology Hepatitis C - genetics Hepatitis C - metabolism Hepatitis C - virology hepatitis C virus Hepatocytes - metabolism Hepatocytes - virology Host-Microbial Interactions Humans MicroRNAs - genetics MicroRNAs - metabolism mixed cryoglobulinemia Polymorphism, Single Nucleotide Research Article TLR7 Toll-Like Receptor 7 - genetics Toll-Like Receptor 7 - metabolism |
| SummonAdditionalLinks | – databaseName: American Society for Microbiology Open Access dbid: AAUOK link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELamTUi8IH4TBsgIxBMZqe3EzmNbraqADYRWtDfLsS8jokmmJZW2_55zkkZ0YhJvkXNOoruz_X3x-Y6Q9yAlQBTloWO5DYXzQQCcqVAlJnIIH4zoahGcnCbLlfh8Hp_vEbY9CzNosDkyTdlt5I8jm6lP5ayoj5BHJSL0Z8cPYlyr0JMPptPVty_jn5WIez-Ntgk1b_fDuRefzXbWoS5d_78w5u1Qyb_WnsVD8mAAjXTaW_kR2YPqMbnXl5G8eULaJfi46LZo6Jz-LK42Tegrclhw9Pi6buoS-574wLsfp9OGmsrRM7R--LX4DRRhI1wi76aSfq_XN2WNei-aEtu7GvVAZ-Ec1vhu29dBqy7ooivR85SsFsdn82U4VFMIDUKGNoytjbOUG4jBcHAZYp00jyRSYMQgLBIGMmmQbpmcI8hSeR4leMVzKUBEXAF_RvaruoIXhOaQmYxnlsuJE8IlGc62iUn9eYacJ5EKyDuvYr01pu6YBlPaG0J3htBsEpCPWwtoOyQk93Ux1neJfxjFL_tMHHcJzrw5RyGfQLtrQHfSw3jUDp3R5YlQE64EV9JIa1KLdAMyZZnlAXm7dQaNA87vopgK6k2jkS8iJpZcpgF53jvH-CouJKqOJQGRO26z8y27d6riV5fUW3kml4qX_6W6Q3Kf-diaCUOHfkX226sNvEZw1GZvhtHwBwNRCxM priority: 102 providerName: American Society for Microbiology – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9swEBajY7CXsd_zfqGxsaepcyzFkh_GaEJDGEsZoxl9E7J86swSu4sdaP77nWQnW0r7tjcjn5DRnaTvw6f7CHkHUgLEsWNF4iwThU8C4IliKjVxgfDBiKBFMDtJp3Px5Wx49rekUD-BzbXUzutJzVeLw8vfm8-44D91F2DUx-WorA-RXqWC-Svlt_FQkl7FYdYj_bApcx-88bbK5tVeuCGbZpnsHU6hhv91wPNq_uQ_B9LkPrnXI0l61Ln-AbkF1UNyp9OW3Dwi7RR8snRbNnRMf5SrdcO8TIeFgh5f1k29xL4zn433_eSooaYq6CmGBPta_gKKWBIukIxTSb_Vi82yRmeUzRLbg3A90BEbwwLHtp04WnVOJ0G35zGZT45Px1PWSywwgziiZUNrh3nGDQzBcChyBECZiyXyYgQmSSwM5NIgBzOOI_JSzsUpPnEnBYiYK-BPyEFVV_CMUAe5yXluuRwUQhRpjltwajJ_ycHxNFYReeunWG9drAP9SJT2jtDBEToZROTD1gPa9lXKvVjG4ibz9zvzi648x02GI-_OnZGvqh0a6tW57hepLjBCC5cKNeBKcCWNtCazyEEgVzaxPCJvtsGgcRX6XyumgnrdaCSRCJQll1lEnnbBsRuKC4lTl6QRkXths_ct-2-q8meo9K08vcvE8__x8S_I3cTn4wwSjPeX5KBdreEVAqo2fx2Wyh8jBx6p priority: 102 providerName: Scholars Portal |
| Title | Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34724826 https://journals.asm.org/doi/10.1128/mBio.02764-21 https://www.proquest.com/docview/2592317379 https://pubmed.ncbi.nlm.nih.gov/PMC8561394 https://doaj.org/article/d86adf6481384387a7ca9c882eb8c2c3 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1db9MwFLVQERIvaHyHwWQE4omwxHZj57GtViqgA6EV9S1y7BuIaJNpSSX277l20qpFTLzwYkWJrVj2sX2ucnMOIa9BSoAoKkLLChMK65IAOFOhSnRkkT5o4b0I5ufJbCE-LIfLPasvlxPWyQN3A3dqsZUtEqFirgRXUkujU4O8EHJlmPE6n3jm7QVTfg_mDqvRVlSTqdP1uKzfYQyWiNDpgg50s2YHZ5GX7P8bz_wzXXLv_JkekXs9caSjrsP3yS2oHpA7nZXk9UPSzsDlRrdlQyf0W3m1aULnymHA0rNfdVOvse3cJd99PR81VFeWXiACwk_lT6BIHeESY28q6Zd6db2ucezLZo33vU890HE4gRW-23ReaNV3OvU2PY_IYnp2MZmFvaNCqJE2tOHQmGGecg1D0BxsjnwnLSKJYTDyEBYJDbnUGHLpgiPRUkURJXjFCylARFwBf0wGVV3BU0ILyHXOc8NlbIWwSY47bqJT909DwZNIBeSVG-KsXxJN5qMNpjI3EZmfiIzFAXm7nYHM9KLkzhtjdVP1N7vql50ax00Vx246d5WciLa_gdDKemhl_4JWQF5uwZDhonNfUnQF9abJMGZEXiy5TAPypAPH7lVcSBw6lgREHsDmoC-HT6ryhxf2Vi6aS8Wz_9H5Y3KXufSbmCHen5NBe7WBF8if2vyE3B6NFp8_nvglg-X7ZYzlXKjfeyYbBA |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLamTgheEHfC1QjEE9nS2Imdx7ZaVVhbEGrR3izHPoFsTTItqcT-PcdpWtGJSbxFji1H5-J8xz4-HyEfQAiAIMh8G2bG59YlAbBQ-jLWgUX4oHnLRTCbx5Ml_3IWnR2QeHsX5tzx8q7qI10X7Tm-c2y3Ed3xEcrjYphXRxhLxdx398cP3blh1COHg8Hy6-ludyVgzlaDbVHNm-Nw_cUJwr1_UVuy_18482a65F__n_EDcr8DjnSw0fRDcgDlI3JnQyV5_Zg0E3C50U1e0xH9kV-ta9-xchiw9OR3VVcFjp255Lvv80FNdWnpAi3An-YXQBE6wiXG3lTQb9XquqhQ9nldYHvLUw906I9ghXObDRda-ZOOW5qeJ2Q5PlmMJn7HqOBrhA2NHxkTpQnTEIFmYFPEO0kWCAyDEYeEAdeQCo0hl84YAi2ZZUGMTywTHHjAJLCnpFdWJTwnNINUpyw1TPQt5zZOccWNdeLuNGQsDqRH3jsRq84latVGG6FUThGqVYQK-x75tNWAMl1RcseNsbqt-8dd98tNNY7bOg6dOnedXBHttgFtSnU-qSwapM1iLvtMciaFFkYnBkMOSKUJDfPIu60xKHQ6d5KiS6jWtcKYEXGxYCLxyLONceymYlyg6MLYI2LPbPa-Zf9Nmf9qC3tLF80l_MV_ie4tuTtZzKZq-nl--pLcC12uTT9E435Fes3VGl4jWGrSN51n_AGyeg9t |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELemTiBeJr4Jn0YgnshIbTd2HtuyqrCtTGhFe7Mc-wzR2qRaWon995zTtKITk3iLnHMS3Z3t38Xn-xHyHqQESBIfO-ZtLFxIAuBMxSo1iUP4YETDRXA6ScdT8fWid7FH0s1ZmFaD9aGp581GfhjZC-dbPkL1aT4oqkOMpVIRh_Pj-2GjinXIfr8__Xa8_buS8OCryaao5s1-OP_i89nOWtSU7P8XzryZLvnX-jO6Tw5a4Ej7a0s_IHtQPiR31lSS14_IcgwhN3pZ1HRIfxRXqzoOrBwWHD36XdXVHPuehuS775N-TU3p6Dl6QHxSXAJF6AgLjL2ppGfV7Hpeoe6Leo7tDU890EE8hBm-26650MqfdNTQ9Dwm09HR-XAct4wKsUHYsIx71vbyjBvogeHgcsQ7mU8khsGIQ1giDOTSYMhlPEegpbxPUrziXgoQCVfAn5BOWZXwjFAPucl5brnsOiFcmuOMm5osnGnwPE1URN4FFeuNQXUTbTClgyF0YwjNuhH5uLGAtm1R8sCNMbtN_MNWfLGuxnGb4CCYcysUimg3DehSuh2T2qFDOp8K1eVKcCWNtCazGHJAriyzPCJvN86gcdCFnRRTQrWqNcaMiIsll1lEnq6dY_sqLiSqjqURkTtus_Mtu3fK4ldT2FuFaC4Tz_9LdW_I3bPPI33yZXL8gtxjIdWmy9C3X5LO8moFrxArLfPX7cD4A4WZDwk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatitis+C+Virus-Induced+Exosomal+MicroRNAs+and+Toll-Like+Receptor+7+Polymorphism+Regulate+B-Cell+Activating+Factor&rft.jtitle=mBio&rft.au=Tsai-Ling+Liao&rft.au=Yi-Ming+Chen&rft.au=Shie-Liang+Hsieh&rft.au=Kuo-Tung+Tang&rft.date=2021-12-21&rft.pub=American+Society+for+Microbiology&rft.eissn=2150-7511&rft.volume=12&rft.issue=6&rft_id=info:doi/10.1128%2FmBio.02764-21&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_d86adf6481384387a7ca9c882eb8c2c3 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2150-7511&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2150-7511&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2150-7511&client=summon |